Treatment of Renal Cell Carcinoma with Interferon

  • M. P. Wirth


The successful use of interferon-α (IFN- α) in the treatment of metastasized renal cell carcinoma (RCC) was first reported in 1983 [5]. Since that time the efficacy of IFN- α in RCC has been tested in numerous studies. Recently the two other IFN, namely IFN-β and IFN-γ, have also been used in the treatment of RCC. Although we know much more about the subtypes and the action of IFN today than we did in 1983, the exact mechanisms of tumor control by IFN have not yet been elucidated.


Renal Cell Carcinoma Clin Oncol Objective Response Rate Metastatic Renal Cell Carcinoma Advanced Renal Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Edsmyr F, Esposti PL, Andersson L, Steineck G, Lagergren C, Strander H (1985) Interferon therapy in disseminated renal cell carcinoma. Radiother Oncol 4: 21–26PubMedCrossRefGoogle Scholar
  2. 2.
    Fujita T, Asano H, Naide Y, Ono Y, Onshima S, Suzuki K, Aso Y etal. (1988) Antitumor effects of human lymphoblastoid interferon on advanced renal cell carcinoma. J Urol 139: 256–258PubMedGoogle Scholar
  3. 3.
    Garnick MB, Reich SD, Maxwell B, Coval-Goldsmith S, Richie JP, Rudnick SA (1988) Phase I/n study of recombinant interferon gamma in advanced renal cell carcinoma. J Urol 139: 251–255PubMedGoogle Scholar
  4. 4.
    Huber C, Aulitzky W, Gastl G, Aulitzky WE, Herold M, Frick J (1989) Treatment of metastasizing renal cell carcinoma with an optimum biological response modifying dose of r-IFN-gamma. J Biol Resp Mod 8: 335Google Scholar
  5. 5.
    deKernion JB, Sarna JB, Figlin R, Lindner A, Smith RB (1983) The treatment of renal cell carcinoma with human leukocyte alpha-interferon. J Urol 130: 1063–1066PubMedGoogle Scholar
  6. 6.
    Kirkwood JM, Harris JE; Vera R, Sandler S, Fischer DS, Khandekar J, Ernstoff MS etal. (1985) A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial. Cancer Res 45: 863–871PubMedGoogle Scholar
  7. 7.
    Koiso K and Recombinant Human Interferon Gamma (S-6810) Research Group on Renal Cell Carcinoma (1987) Phase II study of recombinant human interferon gamma (S-6810) on renal cell carcinoma. Cancer 60: 929–933Google Scholar
  8. 8.
    Krown SE (1987) Interferon treatment of renal cell carcinoma. Current status and future prospects. Cancer 59: 647–651PubMedCrossRefGoogle Scholar
  9. 9.
    Muss HB, Constanzi JJ, Leavitt R, Williams RD, Kempf RA, Pollard R, Ozer H etal. (1987) Recombinant alpha interferon in renal cell carcinoma: a randomized trial of two routes of administration. J Clin Oncol 5: 286–291PubMedGoogle Scholar
  10. 10.
    Neidhart JA, Gagen MM, Young D, Tuttle R, Melink TJ, Ziccairelli A, Kisner D (1984) Interferon-alpha therapy of renal cancer. Cancer Res 44: 4140–4143PubMedGoogle Scholar
  11. 11.
    Neidhart J, Gagen M, Kisner R, Tuttel R, Whisman J (1984) Therapy of renal cancer with low (LD) and high (HD) dose regimens of human lymphoblastoid interferon (HBLJ; Wellferon ). Proc Am Soc Clin Oncol 3: 60Google Scholar
  12. 12.
    Otto U, Schneider A, Denkhaus H, Conrad S (1988) Die Behandlung des meta-stasierten Nierenkarzinoms mit rekombinantem alpha-2-oder gamma-Interferon. Ergebnisse zweier klinischer Phase-Ii-bzw. -HI-Studien. Onkologie 11: 185–191PubMedCrossRefGoogle Scholar
  13. 13.
    Quesada JR, Swanson DA, Trindade A, Gutterman JU (1983) Renal cell carcinoma: Antitumor effects of leukocyte interferon. Cancer Res 43: 940–947Google Scholar
  14. 14.
    Quesada JR, Rios A, Swanson D, Trown P, Gutterman JU (1985) Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma. J Clin Oncol 3: 1522–1528PubMedGoogle Scholar
  15. 15.
    Quesada JR, Swanson DA, Gutterman JU (1985) Phase II study of interferon alpha in metastatic renal cell carcinoma. J Clin Oncol 3: 1086–1092PubMedGoogle Scholar
  16. 16.
    Rinehart J, Malspeis L, Young D, Neidhart J (1986) Phase I/EE trial of human recombinant beta-interferon serine in patients with renal cell carcinoma. Cancer Res 46: 5364–5367PubMedGoogle Scholar
  17. 17.
    Sarna G, Figlin R, deKernion J (1987) Interferon in renal cell carcinoma. The UCLA experience. Cancer 59: 610–612Google Scholar
  18. 18.
    Umeda T, Niijima T (1986) Phase II study of alpha-interferon on renal cell carcinoma. Summary of three collaborative trials. Cancer 58: 1231–1235PubMedCrossRefGoogle Scholar
  19. 19.
    Vugrin D, Hood L, Taylor W, Laszlo J (1985) Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma. Cancer Treat Rep 69: 817–820PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • M. P. Wirth
    • 1
  1. 1.Department of UrologyUniversity of Würzburg, Medical SchoolWürzburgGermany

Personalised recommendations